PRKDC and glioblastoma: The CXCR1 signaling promotes proliferation, inhibits apoptosis, and shortens the S phase in DNA-PK+ glioblastoma cells via activation of the ERK1/2 pathway, which can be blocked by CXCR1 knockdown.